CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (CYYNF) Stock Price, Quote, News & History

CYYNFOTCPK

Trade with Public

$0.00400

At close: Jul 10, 5:00 PM EST

OverviewShort Interest

Key Statistics

Open

Volume / Avg.

0 / 3.19K

Day Range

- - -

52 Wk Range

0.00 - 0.22

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.01

Recent Cynata Therapeutics Ltd News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

114.76K

Free Cash Flow (TTM)

-8.18M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-8.07M

Valuation Metrics

Enterprise Value

$343.69K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.42

Earnings Yield % (TTM)

-644.50%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.01

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$5.05M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 3.19K

Day Range

- - -

52 Wk Range

0.00 - 0.22

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.01

About

Sector

Health Care

Industry

Biotechnology

Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus manufacturing platform. There are currently three act...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (CYYNF) stock?

You can purchase shares of CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (OTCPK:CYYNF) through any online brokerage.

View our list of the best stock brokerages

Who are CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (CYYNF) competitors?

There are no as such competitors for CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd..

What is the forecast, or price target, for CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (CYYNF) stock?

There is no analysis for CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. to provide a consensus price target.

What is the current price for CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (CYYNF)?

The stock price for CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (OTCPK: CYYNF) is $0.004 last updated June 30, 2026 at 10:06 AM EDT.

Does CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (CYYNF) pay a dividend?

There are no upcoming dividends for CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd..

When is CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (OTCPK:CYYNF) reporting earnings?

CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. does not have any upcoming earnings scheduled.

Is CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (CYYNF) going to split?

There is no upcoming split for CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd..

What sector and industry does CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. (CYYNF) operate in?

CYNATA THERAPEUTICS LTD by Cynata Therapeutics Ltd. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.